
Editorial: As sugar is attacked, Chicago candymaker Ferrara keeps the Nerds coming
These are nervous times in the food industry. Secretary of Health and Human Services Robert F. Kennedy is centralizing control of health-related agencies under his authority. He's advancing his 'Make America Healthy Again' campaign by, paradoxically, slashing more than 80,000 from the federal health workforce. That sets the stage for what Chicago's Journal of the American Medical Association recently quoted in a headline as, 'guaranteed pandemonium.'
Among his bold statements about the modern food supply, Kennedy has said Americans are being 'unknowingly poisoned' by canola and soybean oil, for instance, and described the sale of so-called 'ultra-processed' food like hot dogs and chips to Native Americans as a 'genocide.' He wants to ban long-approved dyes and preservatives. And he's angling to use government power to remake school lunches and prevent food-stamp recipients from shopping in some of the most popular sections of the grocery aisles. Many are applauding him.
And as for the sweet stuff most Americans enjoy in moderation? 'Sugar is poison,' Kennedy said last month, and Americans need to know that it's poison.
We share his goal of food policy that yields a healthy population. We also have an interest in Chicago-based businesses.
The $2 billion Chicago company that makes Lemonheads, Jelly Bellies and Nerds unsurprisingly takes a different view from Kennedy. As Ferrara Candy Co.'s Katie Duffy says, 'Everything we produce is safe to eat.'
This page recognizes that sugar has contributed to the obesity epidemic and we don't think that all of Kennedy's warnings are without foundation. But we've also long recoiled against Uncle Sam telling Americans what to eat. If a food product is safe from a scientific standpoint, the government has no business blocking it from the marketplace. Food producers should be honest about what's in their products so people can make informed decisions. Armed with that information, we believe people are smart enough to make their own decisions without Nanny State intervention.
Candy is a good example: Do you know anybody who puts Laffy Taffy at the center of the plate for dinner or serves a steak with a side of Twizzlers? Just about everyone understands that too much sugar in the diet can be unhealthy. But people also realize they can safely enjoy a treat now and then without bringing on the deadly, chronic conditions that Kennedy invokes in scare tactics that we worry will backfire.
For now, the food industry is proceeding with cautious optimism. At Ferrara, which has a long, proud history of making candy in Chicago, the business outlook is still positive, according to Greg Guidotti, chief marketing officer.
Taking a break from handing out Freeze-Dried Sweet Tarts and Nerds Gummy Clusters at a recent trade show in Indianapolis, Guidotti reaffirmed that his fast-growing company sees its future in sugar-based candy (called just 'Sugar' in industry parlance, to distinguish it from 'Chocolate'). 'We have intentions to be the global leader in Sugar,' Guidotti said. 'We're definitely the U.S. leader.'
The company's 'shining star,' as he puts it, is the Nerds business, which he said has grown from just $70 million in sales pre-pandemic to $900 million today. 'Nerds Clusters changed the game,' he explained, referencing a product that combines the traditionally crunchy Nerds with those with a gummy center.
The National Confectioners Association, which runs the candy show, is focused on ensuring the FDA can do its traditional job. Indeed, the U.S. needs a central regulator to determine what's , and as we've written before, food producers should not knowingly add dangerous ingredients into our food supply. And while many are focused on distributing safe, delicious products, it's true that there are major food manufacturers that prioritize low-cost production over guaranteeing a safe, healthy food supply.
The FDA must retain the capacity to evaluate food based on science and enact policy that follows science.
Consumers are still making room in their budgets for sweets. Last year, retail sales of chocolate, candy, gum and mints topped $54 billion. With sales like this, it's hard not to acknowledge that Americans are consuming a lot of sweets.
We're all for enjoying sugar — and Sugar — in moderation. But let's not lose our heads.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
A Health Crisis Cost You a Bundle. How to Claw It Back.
Americans undergoing a major medical event or relying on assisted care at home or in a facility should put the deduction on their radar, tax experts say. 'Make sure you've got proof of payment for any out-of-pocket cost, everything to support that deduction,' said Henry Grzes, lead manager for tax practice and ethics with the American Institute of CPAs. What Is the Medical Tax Deduction?
Yahoo
4 hours ago
- Yahoo
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus


Newsweek
6 hours ago
- Newsweek
Egg Recall Map Shows Warnings Issued to Customers in 9 States
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. August Egg Company has issued a recall on Friday for 1,700,000 brown cage-free and certified organic brown eggs due to potential fears of salmonella. Newsweek reached out to the company after hours via phone Friday night for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that salmonella is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. What To Know The FDA says in its alert that some of the eggs were distributed to grocery stores including Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less and Ralphs. Those eggs were distributed from February 3, 2025, to May 15, 2025, with sell by dates of March 4, 2025, and June 4, 2025, in both California and Nevada. The FDA says additional eggs were distributed from February 3, 2025, to May 6, 2025, with sell by dates of March 4, 2025, and June 19, 2025, in Walmart stores in Illinois, Indiana, Nebraska, New Mexico, California, Washington, Nevada, Arizona and Wyoming. The plant code numbers for the recalled eggs can be found printed on the package and are P-6562 or CA5330 with Julian Dates from 32 to 126, the FDA says. The Julian Dates are codes of three to seven digits and represent the date that the food was packaged or manufactured. "This recall is associated with an ongoing outbreak investigation of Salmonella Enteritidis illnesses" the alert says, adding the investigation is related to products distributed in the nine states. The FDA alert also has a chart of the Julian Dates with corresponding item names. What People Are Saying The FDA alert, in part: "August Egg Company is not selling fresh shell eggs at this time. Our firm has voluntarily been diverting eggs to an egg-breaking plant for over 30 days, which pasteurizes the eggs and kills any potential foodborne pathogens." August Egg Company in the FDA alert: "August Egg Company of Hilmar, CA is voluntarily recalling 1,700,000 dozen shell eggs processed at our California plant and sold to various grocery customers. This recall has been initiated due to possible Salmonella enteritidis contamination, which poses a health risk. With that in mind, we believe it is appropriate out of an abundance of caution to conduct this voluntary recall, as consumers may still have these eggs in their homes. "It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens. "August Egg Company's internal food safety team also is conducting its own stringent review to identify what measures can be established to prevent this situation from recurring. We are committed to addressing this matter fully and to implementing all necessary corrective actions to ensure this does not happen again." What Happens Next Customers with additional questions can call August Egg Company at 1-800-710-2554 from 9 a.m. and 5 p.m. PT and can also return the eggs to the original place of purchase for a refund.